Blood Products Market Report - (Growth and Size 2031)
The Blood Products Market is expected to register a CAGR of 4.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product Type (Platelets, Fresh Frozen Plasma (FFP), Red Blood Cells (RBCs), White Blood Cells (WBCs), Others); End User (Hospital, Blood Station, Others)
The Report Offers the Value in USD for the above analysis and segments.
The report Blood Products Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Blood Products Market Segmentation
Product Type- Platelets
- Fresh Frozen Plasma
- Hospital
- Blood Station
- Others
Strategic Insights
Blood Products Market Growth Drivers- Increased Demand for Blood Products Due to the Increasing Global Healthcare: The demand for blood products is growing further, due to the growing healthcare infrastructure established everywhere across the world and the rising volumes of patients-including emergencies, surgery, and chronic disease management. Rising numbers of surgeries, trauma, and complex medical conditions require more blood transfusions, plasma therapies, and other blood-related products as adjuncts for patient recovery and treatment.
- Incorporating into increasing incidence of blood diseases: The increasing incidence of blood disorders such as anemia, hemophilia, and sickle cell disease is expected to drive the blood products market. Such patients require life-long blood or clotting factor therapy through transfusions, which increases their demand for red cells, plasma, and clotting factors.
- Advancement in Blood Processing and Storage: Advances in technology for collection, processing, and storage of blood ensure better safety of blood products and their processing. Pathogen-reduced blood products and improved storage systems result in longer shelf lives and risk-free transfusions. As a result, hospitals and clinics are going to spend more in inventories of blood products, thereby boosting the market.
- Growing Plasma-Derived Therapies: Plasma-derived therapies are increasingly becoming popular in this field of treatment of immune disorders, hemophilia, and other chronic diseases. The rising demand for IVIG and clotting factor implies that these applications are expanding towards the treatment of several diseases, making plasma a key driver for the global blood products market.
- Increasing Awareness About Blood Donation: Increased voluntary donations of blood- The campaigns for awareness and drives for blood donation have increased voluntary donations of blood. Regular supplies of the blood products are ensured, and hence the occurrence of shortages is reduced; thus, growth in the market has to be maintained, and adequate quantities to be supplied to hospitals and clinics.
- Trend Shift to Artificial Blood Products: Artificial blood and blood substitutes are becoming a new rising market trend in relation to research. Synthetic blood substitutes become advanced due to shortfalls in the supply of blood that replace it where donor blood is either unavailable or out of reach, in military use or regions that hardly possess easy access to blood banks
- Expansion of Emerging Markets: The TB diagnosis and treatment market witnesses huge opportunities for growth in Asia, Africa, and Latin America. The emergence of new economies in these regions involves rising cases of TB along with increased attention to healthcare infrastructure development. Thus, companies investing in these markets have ample opportunities to gain more market share by providing cost-effective diagnostic tools and treatment options tailored according to local requirements.
- New TB Vaccines Development: However, though some developed vaccines are available, there is a very vast opportunity for better development of TB vaccines. With currently most efforts on new vaccine candidates that would perhaps provide stronger and longer-lasting defense against the disease, including formulations of new drug-resistant TB targets, an opportunity for both the public health efforts and the innovation private sector is created.
- Digitization of Health Solutions: Telemedicine and mobile health applications in digital health technologies open new avenues to TB diagnosis and management. The digital solution can be useful in monitoring patients' adherence to the treatment course, making remote consultations possible, managing large-scale TB control programs, all with better outcomes and efficiency Improving the healthcare infrastructure and spreading awareness about diabetes management has created an increasing demand for such technology. Companies can capitalize on this trend by making their artificial pancreas systems accessible and flexible to employ in such regions, thus improving patients' access to proper diabetes care.
- Diabetic Device Manufacturers and Tech Companies Partnership Opportunities: Surely this is an area where the diabetic device manufacturers can collaborate with tech companies to make even more innovative artificial pancreas systems. From the developments that have taken place in AI, machine learning, and data analytics, such collaborations are more likely to create algorithms advanced in glucose level management. A major outcome at the end is a better patient outcome accompanied by fully integrated systems that promise to provide streamlined diabetes management experiences.
- Pediatric Diabetes Care: Significant Opportunity Pediatric diabetes care might perhaps rank as one of the significant opportunities in the market which artificial pancreas could offer. The majority of the solutions regarding diabetes management have been derived from particularly earmarked needs and lifestyles of children; thus, tailored solutions are far more than what can be offered to adults. Tailor-made artificial pancreas systems for young patients may lead to a higher quality of life for them and treatment adherence. It fills an important gap in the market and creates long-term brand loyalty towards families.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Products Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Blood Products Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
CSL Kedrion S.p.A BPL Inc. Octapharma AG Mitsubishi Tanabe Pharma Corporation
The market is expected to grow at a CAGR of 10.2%
Asia Pacific region dominated the Blood Products Market in 2023
North America region dominated the Blood Products Market in 2023
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023: 2031)
The Blood Products Market is estimated to witness a CAGR of 4.5% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Products Market - By Product Type
1.3.2 Blood Products Market - By End User
1.3.3 Blood Products Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. BLOOD PRODUCTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BLOOD PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PLATELETS
7.3.1. Overview
7.3.2. Platelets Market Forecast and Analysis
7.4. FRESH FROZEN PLASMA (FFP)
7.4.1. Overview
7.4.2. Fresh Frozen Plasma (FFP) Market Forecast and Analysis
7.5. RED BLOOD CELLS (RBCS)
7.5.1. Overview
7.5.2. Red Blood Cells (RBCs) Market Forecast and Analysis
7.6. WHITE BLOOD CELLS (WBCS)
7.6.1. Overview
7.6.2. White Blood Cells (WBCs) Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BLOOD PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. BLOOD STATION
8.4.1. Overview
8.4.2. Blood Station Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. BLOOD PRODUCTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Blood Products Market Overview
9.1.2 North America Blood Products Market Forecasts and Analysis
9.1.3 North America Blood Products Market Forecasts and Analysis - By Product Type
9.1.4 North America Blood Products Market Forecasts and Analysis - By End User
9.1.5 North America Blood Products Market Forecasts and Analysis - By Countries
9.1.5.1 United States Blood Products Market
9.1.5.1.1 United States Blood Products Market by Product Type
9.1.5.1.2 United States Blood Products Market by End User
9.1.5.2 Canada Blood Products Market
9.1.5.2.1 Canada Blood Products Market by Product Type
9.1.5.2.2 Canada Blood Products Market by End User
9.1.5.3 Mexico Blood Products Market
9.1.5.3.1 Mexico Blood Products Market by Product Type
9.1.5.3.2 Mexico Blood Products Market by End User
9.2. EUROPE
9.2.1 Europe Blood Products Market Overview
9.2.2 Europe Blood Products Market Forecasts and Analysis
9.2.3 Europe Blood Products Market Forecasts and Analysis - By Product Type
9.2.4 Europe Blood Products Market Forecasts and Analysis - By End User
9.2.5 Europe Blood Products Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Blood Products Market
9.2.5.1.1 Germany Blood Products Market by Product Type
9.2.5.1.2 Germany Blood Products Market by End User
9.2.5.2 France Blood Products Market
9.2.5.2.1 France Blood Products Market by Product Type
9.2.5.2.2 France Blood Products Market by End User
9.2.5.3 Italy Blood Products Market
9.2.5.3.1 Italy Blood Products Market by Product Type
9.2.5.3.2 Italy Blood Products Market by End User
9.2.5.4 Spain Blood Products Market
9.2.5.4.1 Spain Blood Products Market by Product Type
9.2.5.4.2 Spain Blood Products Market by End User
9.2.5.5 United Kingdom Blood Products Market
9.2.5.5.1 United Kingdom Blood Products Market by Product Type
9.2.5.5.2 United Kingdom Blood Products Market by End User
9.2.5.6 Rest of Europe Blood Products Market
9.2.5.6.1 Rest of Europe Blood Products Market by Product Type
9.2.5.6.2 Rest of Europe Blood Products Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Blood Products Market Overview
9.3.2 Asia-Pacific Blood Products Market Forecasts and Analysis
9.3.3 Asia-Pacific Blood Products Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Blood Products Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Blood Products Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Blood Products Market
9.3.5.1.1 Australia Blood Products Market by Product Type
9.3.5.1.2 Australia Blood Products Market by End User
9.3.5.2 China Blood Products Market
9.3.5.2.1 China Blood Products Market by Product Type
9.3.5.2.2 China Blood Products Market by End User
9.3.5.3 India Blood Products Market
9.3.5.3.1 India Blood Products Market by Product Type
9.3.5.3.2 India Blood Products Market by End User
9.3.5.4 Japan Blood Products Market
9.3.5.4.1 Japan Blood Products Market by Product Type
9.3.5.4.2 Japan Blood Products Market by End User
9.3.5.5 South Korea Blood Products Market
9.3.5.5.1 South Korea Blood Products Market by Product Type
9.3.5.5.2 South Korea Blood Products Market by End User
9.3.5.6 Rest of Asia-Pacific Blood Products Market
9.3.5.6.1 Rest of Asia-Pacific Blood Products Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Blood Products Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Blood Products Market Overview
9.4.2 Middle East and Africa Blood Products Market Forecasts and Analysis
9.4.3 Middle East and Africa Blood Products Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Blood Products Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Blood Products Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Blood Products Market
9.4.5.1.1 South Africa Blood Products Market by Product Type
9.4.5.1.2 South Africa Blood Products Market by End User
9.4.5.2 Saudi Arabia Blood Products Market
9.4.5.2.1 Saudi Arabia Blood Products Market by Product Type
9.4.5.2.2 Saudi Arabia Blood Products Market by End User
9.4.5.3 U.A.E Blood Products Market
9.4.5.3.1 U.A.E Blood Products Market by Product Type
9.4.5.3.2 U.A.E Blood Products Market by End User
9.4.5.4 Rest of Middle East and Africa Blood Products Market
9.4.5.4.1 Rest of Middle East and Africa Blood Products Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Blood Products Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Blood Products Market Overview
9.5.2 South and Central America Blood Products Market Forecasts and Analysis
9.5.3 South and Central America Blood Products Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Blood Products Market Forecasts and Analysis - By End User
9.5.5 South and Central America Blood Products Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Blood Products Market
9.5.5.1.1 Brazil Blood Products Market by Product Type
9.5.5.1.2 Brazil Blood Products Market by End User
9.5.5.2 Argentina Blood Products Market
9.5.5.2.1 Argentina Blood Products Market by Product Type
9.5.5.2.2 Argentina Blood Products Market by End User
9.5.5.3 Rest of South and Central America Blood Products Market
9.5.5.3.1 Rest of South and Central America Blood Products Market by Product Type
9.5.5.3.2 Rest of South and Central America Blood Products Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BLOOD PRODUCTS MARKET, KEY COMPANY PROFILES
11.1. CSL
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. KEDRION S.P.A
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BPL INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. OCTAPHARMA AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MITSUBISHI TANABE PHARMA CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.CSL
2.Kedrion S.p.A
3.
4.BPL Inc.
5.Octapharma AG
6.Mitsubishi Tanabe Pharma Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For